Track topics on Twitter Track topics that are important to you
AstraZeneca’s CEO Pascal Soriot has described 2017 as a “defining” year for the company, with a series of new products gaining traction and the worst of a series of patent losses in the past. In a third-quarter results call, Soriot said that...
Original Article: AZ chief Soriot bullish despite falling salesNEXT ARTICLE
AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009. it is a global company, working in more than 100 countries, and employing 62,000 people, around a sixth of which are dedic...